期刊文献+

中药疏肝舒乳颗粒对实验性乳腺增生症形态学的影响 被引量:5

The Morphologic Effects of Shu Gan Shu Ru Granule on the Hyperplastic Disease of Breast of Experimental Rabbit
在线阅读 下载PDF
导出
摘要 目的通过家兔乳腺增生症(HDB)模型的复制,观察疏肝舒乳颗粒(SGSR)对HDB形态学的影响,探讨其治疗HDB的机理。方法采用雌二醇肌肉内注射法,复制家兔乳腺增生症模型,经SGSR干预治疗后,观察动物HDB的形态学改变。依组织增生程度的不同HDB模型被分为正常对照及轻、中、重三级(0-Ⅲ)。结果经SGSR治疗后,增生的多层乳腺导管上皮回复为单层柱状上皮,部分上皮发生退行性改变及变性萎缩,同造模组相比,有统计学差异(P<0.01)。结论疏肝舒乳颗粒是治疗HDB的有效药物,其治疗HDB的机理之一是使乳腺导管上皮及腺上皮发生退行性改变和变性萎缩。 Objective To observe the the morphologic effects of Shu Gan Shu Ru granule (SGSR) on hyperplastic disease of breast (HDB) of experimental rabbits and investigate the mechanism of SGSR to treat HDB, this study was carried out by means of the rabbit model of HDB. Methods The method of intramuscular injection of benzoate estradiol on rabbits to duplicate the model of HDB was applied, then the rabbits were treated with SGSR and the morphologic changes of animal HDB were observed. According to the extent of lesion HDB model was divided into normal, mild, moderate and severe degrees (0-Ⅲ). Results After treatment the hyperplastic and dysplastic multi - layer duct epithelia returned normal and part of the epithelia showed atrophic disappearance and there were statistically differences(P 〈 0.01 ). Conclusion SGSR is an effective drug of treating HDB. One of the treatment mechanism was that it not only restrains the hyperplasia / dysplasia of duct epithelia but also made it retrocession and atrophic changed.
作者 王成鑫 李艳
出处 《时珍国医国药》 CAS CSCD 北大核心 2006年第6期953-954,共2页 Lishizhen Medicine and Materia Medica Research
关键词 疏肝舒乳颗粒 乳腺增生症 动物模型 形态学 Shu Gan Shu Ru Granules Hyperplastic disease of breast Animal model Morphology
  • 相关文献

参考文献9

二级参考文献35

  • 1李宁丽.免疫系统中细胞的程序性死亡[J].上海免疫学杂志,1994,14(1):59-61. 被引量:8
  • 2谭爱军,吴克兰,黄铭西,何尚浦.β-胡萝卜素对小鼠鸟氨酸脱羧酶活性及表皮乳头状瘤的抑制[J].中华预防医学杂志,1995,29(6):360-361. 被引量:4
  • 3周道洪.-[J].中国免疫学杂志,1986,(1):39-39.
  • 4Kuna zawa y.-[J].国外医学:中医中药分册,1986,8(3):22-22.
  • 5方积年.-[J].药学学报,1986,21(12):944-944.
  • 6胡国俊.-[J].中国免疫学杂志,1995,11(2):163-163.
  • 7回允中译.阿克曼病理学[M].沈阳:辽宁教育出版社,1999.1581—1582.
  • 8Carol A, Bodian, Dr, P. H, Karl H. Perzin, et al. Reproducibility and vali-dity of Pathologic Classifications of Benign Brest Disease and implica-tions for clinical applications[J]. Cancer june 15,1993,3908-3913.
  • 9Cancer comrnittee of the college of American pathologist. Is “fibrocystic disease” of the breast precancerous? [J]. Arch pathol lab med, 1986, 110:171-173.
  • 10Walker R. The pathology of precancerous breast diseast[J ]. Pathol Annu, 1995, 29(2) :75-97.

共引文献121

同被引文献13

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部